Market for Protein Sequencing Expected to Grow at 3.7% CAGR

Protein sequencing, a fundamental process in life science research and biotechnology development, involves determining the precise order of amino acids within a protein molecule. This sequence dictates the protein’s structure, function, and biological activity. It starts at the genetic level, where DNA guides protein synthesis by transcribing into messenger RNA and translating into amino acids that form a polypeptide chain. This chain undergoes folding and post-translational modifications to become a functional protein.

Traditional methods like Edman degradation allowed step-by-step amino acid identification, but mass spectrometry-based techniques have become the industry standard due to their speed, sensitivity, and ability to handle complex protein samples. These modern approaches help identify unknown proteins, detect structural variations, and confirm protein modifications with high accuracy.

Protein sequencing plays a crucial role in various sectors such as pharmaceuticals, diagnostics, biotechnology, and academic research. It aids in drug discovery, biomarker identification, quality control of biologics, and understanding disease mechanisms at a molecular level. With advancements in analytical instrumentation and bioinformatics, protein sequencing is becoming more efficient and scalable, supporting innovation in precision medicine, therapeutic development, and biological research.

In 2023, the protein sequencing market generated USD 3.2 billion in revenue and is projected to grow at a CAGR of 3.7%, reaching approximately USD 4.7 billion by 2033. The market is segmented by product and service type, application, and end-users. Protein sequencing products dominated in 2023, accounting for 76% of total revenue, with bio-therapeutics emerging as the leading application area. Academic institutes and research centers comprised the largest end-user group.

Regionally, North America led the protein sequencing market in 2023, capturing a 41.2% revenue share. This was attributed to the region’s technological capabilities, healthcare infrastructure, and government funding for proteomics research. In December 2022, the commercial launch of Platinum, the world’s first next-generation single-molecule protein sequencing platform by Quantum-Si Inc., contributed to market expansion. Asia Pacific is expected to witness the highest CAGR, driven by investments in biotechnology and pharmaceutical research.

Emerging trends in protein sequencing include next-generation protein sequencing (NGPS), which enhances accuracy and scalability in proteomics. Integration with artificial intelligence (AI) streamlines protein analysis, and protein language models leverage deep learning to predict structure and function. Enhanced computational methods improve data processing and interpretation, optimizing protein sequencing analysis.

Overall, protein sequencing continues to evolve as a critical technology in life science research and biotechnology, supporting advancements in drug discovery, biomarker identification, and personalized medicine. With growing adoption of modern techniques and technologies, the future of protein sequencing looks promising in driving innovation and understanding biological processes at a molecular level.